Dexcom Inc.
Congress has disclosed 15 buys and 21 sells of DXCM (Dexcom Inc.) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.
Activity Congressional Activity
Round-trip watch Still on the books
Members who disclosed buying DXCM and have not disclosed selling, versus their own entry (the most recent disclosed buy). "Open" means no disclosed sale — never "still holds" — and the % is unrealised, on paper. Not investment advice.
| Member | Entry (last buy) | Entry price | Now | vs entry | Status |
|---|---|---|---|---|---|
| Rob Bresnahan | 2025-05-15 | $85.67 | $82.29 | -3.9% | ↩ near entry |
| Rohit Khanna | 2026-05-01 | $61.35 | $82.29 | +34.1% | in profit |
| Michael McCaul | 2025-09-22 | $69.51 | $82.29 | +18.4% | in profit |
Price as of 2026-10-30. Counted open while disclosed buys outnumber disclosed sells; tracks the price, not exact position size (amounts are ranges).
Fundamentals · FY2026 Valuation
Standard valuation multiples from SEC-reported GAAP financials (trailing twelve months), each compared to the median for —. We use reported GAAP, not forward or adjusted earnings, so our figures can sit higher than sites that do — especially for companies with falling profit. Relative context — not a target price or investment advice.
how it's calculated
how it's calculated
how it's calculated
36 trades Recent Congressional Trades
Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.
| Politician | Chamber | Type | Owner | Date | Disclosure lag | Price move in that window | Amount | Score | Source |
|---|---|---|---|---|---|---|---|---|---|
| Michael McCaul | House | SELL OCR ◆ insider convergence | Spouse | 2026-05-07 | 29 days | +19.6% | $1K–$15K | 9.7 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence | Child | 2026-05-01 | 38 days | +24.9% | $1K–$15K | 19.9 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence | Spouse | 2026-04-13 | 21 days | -4.9% | $1K–$15K | 29.0 | ↗ filing |
| Michael McCaul | House | SELL OCR ◆ insider convergence | Spouse | 2026-02-04 | 29 days | -0.2% | $1K–$15K | 7.3 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider convergence · moderate | Child | 2025-12-05 | 30 days | +1.6% | $1K–$15K | 47.3 | ↗ filing |
| Michael McCaul | House | SELL OCR ◆ insider divergence · moderate | Spouse | 2025-10-27 | 9 days | -16.1% | $15K–$50K | 24.4 | ↗ filing |
| Michael McCaul | House | BUY OCR ◆ insider convergence · moderate | Spouse | 2025-09-22 | 13 days | -3.5% | $1K–$15K | 9.3 | ↗ filing |
| Michael McCaul | House | BUY OCR ◆ insider divergence | Spouse | 2025-08-07 | 29 days | +5.4% | $1K–$15K | 11.6 | ↗ filing |
| Michael McCaul | House | BUY OCR ◆ insider divergence | Spouse | 2025-08-04 | 32 days | +5.6% | $15K–$50K | 30.9 | ↗ filing |
| Michael McCaul | House | BUY OCR ◆ insider divergence | Spouse | 2025-07-30 | 6 days | -15.3% | $1K–$15K | 24.4 | ↗ filing |
| Rob Bresnahan | House | BUY ◆ insider divergence | Self · JP Morgan Brokerage Account | 2025-05-15 | 0 days | 0.0% | $1K–$15K 0.2% of NW |
14.0 | ↗ filing |
| Jefferson Shreve | House | SELL ◆ insider convergence | Self · CRT - Standard Unit Trust | 2025-05-12 | 3 days | +0.7% | $15K–$50K <0.1% of NW |
48.6 | ↗ filing |
| Rob Bresnahan | House | SELL ◆ insider convergence · moderate | Self · JP Morgan Brokerage Account | 2025-04-08 | 0 days | 0.0% | $1K–$15K 0.2% of NW |
33.6 | ↗ filing |
| Michael McCaul | House | BUY OCR ◆ insider divergence · moderate | Spouse | 2025-04-08 | 27 days | +32.3% | $50K–$100K | 62.1 | ↗ filing |
| Jefferson Shreve | House | SELL ◆ insider convergence · moderate | Self · CRT - Standard Unit Trust | 2025-04-07 | 18 days | +16.3% | $15K–$50K <0.1% of NW |
84.7 | ↗ filing |
| Michael McCaul | House | BUY OCR ◆ insider divergence · moderate | Spouse | 2025-03-13 | 23 days | -12.6% | $15K–$50K | 94.9 | ↗ filing |
| Rob Bresnahan | House | BUY ◆ insider divergence · moderate | Self · JP Morgan Brokerage Account | 2025-02-25 | 0 days | 0.0% | $1K–$15K 0.2% of NW |
67.0 | ↗ filing |
| Kevin Hern | House | SELL ◆ insider convergence · moderate | Joint · Hern Family Revocable Trust > Brokerage Investment Account | 2024-12-31 | 2 days | +0.9% | $50K–$100K 0.9% of NW |
58.8 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence · moderate | Child | 2024-09-09 | 23 days | — | $1K–$15K | 75.9 | ↗ filing |
| Josh Gottheimer | House | SELL ◆ insider convergence | Joint · Morgan Stanley - Select UMA Account # 1 | 2023-09-12 | 29 days | — | $1K–$15K <0.1% of NW |
5.5 | ↗ filing |
| Josh Gottheimer | House | SELL ◆ insider convergence | Joint · Morgan Stanley - Select UMA Account # 1 | 2023-08-21 | 17 days | — | $1K–$15K <0.1% of NW |
6.8 | ↗ filing |
| Josh Gottheimer | House | SELL | Joint · Morgan Stanley - Select UMA Account # 1 | 2022-09-28 | 7 days | — | $1K–$15K <0.1% of NW |
8.6 | ↗ filing |
| Kevin Hern | House | BUY | Joint | 2021-07-01 | 1 days | — | $100K–$250K 2.1% of NW |
96.7 | ↗ filing |
| Thomas Suozzi | House | SELL | Self | 2021-06-03 | 27 days | — | $15K–$50K 0.3% of NW |
56.6 | ↗ filing |
| Peter Meijer | House | SELL | Self | 2021-02-16 | 3 days | — | $1K–$15K | 75.9 | ↗ filing |
| Josh Gottheimer | House | SELL | Joint | 2020-12-24 | 12 days | — | $1K–$15K <0.1% of NW |
19.6 | ↗ filing |
| Gilbert Cisneros | House | SELL | Self | 2020-12-22 | 18 days | — | $1K–$15K 0.1% of NW |
52.4 | ↗ filing |
| Susie Lee | House | SELL | Joint | 2020-10-02 | 30 days | — | $1K–$15K 0.2% of NW |
75.9 | ↗ filing |
| Gilbert Cisneros | House | BUY | Self | 2020-09-16 | 27 days | — | $1K–$15K 0.1% of NW |
75.9 | ↗ filing |
| Josh Gottheimer | House | SELL | Joint | 2020-08-13 | 27 days | — | $1K–$15K <0.1% of NW |
15.7 | ↗ filing |
| Josh Gottheimer | House | SELL | Joint | 2020-05-11 | 28 days | — | $1K–$15K <0.1% of NW |
22.3 | ↗ filing |
| Thomas Suozzi | House | BUY | Self | 2020-01-10 | 21 days | — | $1K–$15K 0.1% of NW |
75.9 | ↗ filing |
| Josh Gottheimer | House | SELL | Joint | 2019-07-16 | 29 days | — | $1K–$15K <0.1% of NW |
52.4 | ↗ filing |
| Bradley Schneider | House | SELL | Spouse | 2019-06-20 | 0 days | — | $100K–$250K 1.3% of NW |
97.8 | ↗ filing |
| Josh Gottheimer | House | SELL | Joint | 2019-06-13 | 27 days | — | $1K–$15K <0.1% of NW |
86.8 | ↗ filing |
| Thomas MacArthur | House | SELL | Joint | 2015-05-27 | 5 days | — | $1K–$15K | 75.9 | ↗ filing |
Corporate insiders · SEC Form 4 Insider Activity
What the company's own officers and directors did in DXCM — open-market purchases and sales from SEC Form 4 filings (option exercises, grants and tax withholding are excluded). This is context for the congressional activity above, never a buy/sell signal, and the two datasets are kept separate on purpose. Does convergence mean anything? →
Of the congressional trades in DXCM, 10 coincided with corporate insiders moving the same way within 60 days, and 11 with insiders moving the opposite way. This is co-occurrence only — whether it carries any edge is tested honestly on the convergence page.
| Date | Insider | Role | Type | Size | Source |
|---|---|---|---|---|---|
| 2026-10-27 | Stern Sadie | C-suite | SELL 10b5-1 | $202K | ↗ EDGAR |
| 2026-10-15 | Brown Michael Jon | C-suite | SELL 10b5-1 | $145K | ↗ EDGAR |
| 2026-09-28 | Stern Sadie | C-suite | SELL 10b5-1 | $221K | ↗ EDGAR |
| 2026-09-15 | Brown Michael Jon | C-suite | SELL 10b5-1 | $143K | ↗ EDGAR |
| 2026-09-15 | AUGUSTINOS NICHOLAS | Director | SELL 10b5-1 | $550K | ↗ EDGAR |
| 2026-09-14 | AUGUSTINOS NICHOLAS | Director | SELL 10b5-1 | $130K | ↗ EDGAR |
| 2026-09-10 | Sylvain Jereme M | C-suite | SELL 10b5-1 | $303K | ↗ EDGAR |
| 2026-08-27 | Stern Sadie | C-suite | SELL 10b5-1 | $227K | ↗ EDGAR |
| 2026-08-20 | SAYER KEVIN R | Director | SELL 10b5-1 | $1.7M | ↗ EDGAR |
| 2026-08-20 | SAYER KEVIN R | Director | SELL 10b5-1 | $667K | ↗ EDGAR |
| 2026-08-20 | SAYER KEVIN R | Director | SELL 10b5-1 | $9K | ↗ EDGAR |
| 2026-08-14 | Brown Michael Jon | C-suite | SELL 10b5-1 | $156K | ↗ EDGAR |
| 2026-08-12 | Heller Bridgette P | Director | SELL 10b5-1 | $89K | ↗ EDGAR |
| 2026-08-03 | FOLETTA MARK G | Director | SELL 10b5-1 | $171K | ↗ EDGAR |
| 2026-07-31 | FOLETTA MARK G | Director | SELL 10b5-1 | $160K | ↗ EDGAR |
| 2026-07-20 | SAYER KEVIN R | Director | SELL 10b5-1 | $2.0M | ↗ EDGAR |
| 2026-07-15 | Brown Michael Jon | C-suite | SELL 10b5-1 | $127K | ↗ EDGAR |
| 2026-07-06 | SAYER KEVIN R | Director | SELL 10b5-1 | $1.9M | ↗ EDGAR |
| 2026-06-15 | FOLETTA MARK G | Director | SELL 10b5-1 | $282K | ↗ EDGAR |
| 2026-06-15 | FOLETTA MARK G | Director | SELL 10b5-1 | $15K | ↗ EDGAR |
| 2026-06-15 | Brown Michael Jon | C-suite | SELL 10b5-1 | $128K | ↗ EDGAR |
| 2026-06-04 | Coleman Jon | C-suite | SELL 10b5-1 | $364K | ↗ EDGAR |
| 2026-06-03 | Coleman Jon | C-suite | SELL 10b5-1 | $359K | ↗ EDGAR |
| 2026-05-21 | SAYER KEVIN R | Director | SELL 10b5-1 | $1.9M | ↗ EDGAR |
| 2026-05-15 | Brown Michael Jon | C-suite | SELL 10b5-1 | $102K | ↗ EDGAR |
Combined timeline — Congress & insiders
Both sets of trades on one timeline, newest first, so you can see when they lined up. Congress vs ◆ insider.
| Date | Who | Type | Size | |
|---|---|---|---|---|
| ◆ insider | 2026-10-27 | Stern Sadie C-suite 10b5-1 | SELL | $202K |
| ◆ insider | 2026-10-15 | Brown Michael Jon C-suite 10b5-1 | SELL | $145K |
| ◆ insider | 2026-09-28 | Stern Sadie C-suite 10b5-1 | SELL | $221K |
| ◆ insider | 2026-09-15 | Brown Michael Jon C-suite 10b5-1 | SELL | $143K |
| ◆ insider | 2026-09-15 | AUGUSTINOS NICHOLAS Director 10b5-1 | SELL | $550K |
| ◆ insider | 2026-09-14 | AUGUSTINOS NICHOLAS Director 10b5-1 | SELL | $130K |
| ◆ insider | 2026-09-10 | Sylvain Jereme M C-suite 10b5-1 | SELL | $303K |
| ◆ insider | 2026-08-27 | Stern Sadie C-suite 10b5-1 | SELL | $227K |
| ◆ insider | 2026-08-20 | SAYER KEVIN R Director 10b5-1 | SELL | $1.7M |
| ◆ insider | 2026-08-20 | SAYER KEVIN R Director 10b5-1 | SELL | $667K |
| ◆ insider | 2026-08-20 | SAYER KEVIN R Director 10b5-1 | SELL | $9K |
| ◆ insider | 2026-08-14 | Brown Michael Jon C-suite 10b5-1 | SELL | $156K |
| ◆ insider | 2026-08-12 | Heller Bridgette P Director 10b5-1 | SELL | $89K |
| ◆ insider | 2026-08-03 | FOLETTA MARK G Director 10b5-1 | SELL | $171K |
| ◆ insider | 2026-07-31 | FOLETTA MARK G Director 10b5-1 | SELL | $160K |
| ◆ insider | 2026-07-20 | SAYER KEVIN R Director 10b5-1 | SELL | $2.0M |
| ◆ insider | 2026-07-15 | Brown Michael Jon C-suite 10b5-1 | SELL | $127K |
| ◆ insider | 2026-07-06 | SAYER KEVIN R Director 10b5-1 | SELL | $1.9M |
| ◆ insider | 2026-06-15 | FOLETTA MARK G Director 10b5-1 | SELL | $282K |
| ◆ insider | 2026-06-15 | FOLETTA MARK G Director 10b5-1 | SELL | $15K |
| ◆ insider | 2026-06-15 | Brown Michael Jon C-suite 10b5-1 | SELL | $128K |
| ◆ insider | 2026-06-04 | Coleman Jon C-suite 10b5-1 | SELL | $364K |
| ◆ insider | 2026-06-03 | Coleman Jon C-suite 10b5-1 | SELL | $359K |
| ◆ insider | 2026-05-21 | SAYER KEVIN R Director 10b5-1 | SELL | $1.9M |
FAQ Common questions
How much has Congress traded DXCM?
15 disclosed buys and 21 sells of DXCM (Dexcom Inc.) appear in official congressional financial disclosures.
Is it legal for members of Congress to trade DXCM?
Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.
Where does this data come from?
Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.